Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Acquisition

11th Jul 2011 07:00

RNS Number : 1005K
Synergy Health PLC
11 July 2011
 



Monday 11th July 2011 

 

Synergy Health plc

("Synergy" or "the Company")

 

Acquisition of Malaysian Sterilisation Company

 

- Increases medical device sterilisation capacity in Malaysia

- Develops Asian and global sterilisation network

- Creates a hospital sterilisation reference site

 

Synergy Health (LSE: SYR), a leading global provider of outsourced sterilisation services to the medical device market and healthcare sector, announces the acquisition of Sinagama II Technologies Sdn Bhd (Sterilgamma).

 

Sterilgamma operates a gamma sterilisation facility in Rawang, near Kuala Lumpur and an ethlyene oxide facility in Kulim, near Penang. Sterilgamma also has a joint venture relationship with a second ethylene oxide facility in Port Klang. The business has been in receivership and has been purchased as part of a sale process conducted by an appointed receiver at a value equivalent to 6.2x EBITDA. The business had revenues last year of MYR 20 million (£4.1 million) and will cement Synergy's presence in the Malaysian market alongside existing gamma and ethylene oxide facilities in Kuala Ketil. The capacity expansion will help to maintain the Company's ability to offer a full sterilisation service to its customers. The business will require an element of restructuring prior to delivering financial returns that are in line with the rest of Synergy's sterilisation business.

 

Sterilgamma also has a joint venture with a private hospital group providing outsourced hospital sterilisation services to the Malaysian market. Although still in its embryonic stage it provides an important reference site that could support the development of Synergy's hospital sterilisation network in this region.

 

 

Richard Steeves, Chief Executive of Synergy Health, said:

 

"This acquisition further strengthens our position in Malaysia and the wider Asian region whilst supporting our strategy to expand our international medical device sterilisation network. The acquisition will also allow us to explore opportunities to deliver further hospital sterilisation services in Malaysia."

 

For Further Information:

 

Synergy Health plc

Dr Richard Steeves, Chief Executive

Gavin Hill, Finance Director

Tel: +44 (0) 1793 891 880

 

Financial Dynamics

Ben Brewerton / Susan Quigley

Tel: +44 (0) 20 7831 3113

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQDVLFBFDFBBBF

Related Shares:

SYR.L
FTSE 100 Latest
Value8,596.35
Change99.55